LY266097 hydrochloride

Research use only, not for human use.

LY266097 hydrochloride (LY 266097 hydrochloride) is an antagonist of 5-HT2 with pKis of 7.7, 9.8, and 7.6 for human 5-HT2A, 5-HT2B, and 5-HT2C and can be used in studies about depression.

LY266097 hydrochloride is a selective 5-HT2B receptor antagonist with pKis of 7.7, 9.8, and 7.6 for 5-HT2A, 5-HT2B, 5-HT2C, respectively. 5-HT2B receptor blockade contributes to the research in depression.

LY266097 is a highly selective 5-HT2B receptor antagonist with a pKi of 9.7 for the human cloned 5-HT2B receptor and a 100-fold greater selectivity over human 5-HT2C and 5-HT2A sites.

LY266097 (0.6?mg/kg for 2-day administration) rescues Escitalopram-induced decrease in dopamine (DA) .The administration of LY266097 alone or its addition on the last 3 days of a 14-day Escitalopram regimen increases pyramidal neuron firing and burst activity.Animal Model:Male Sprague-Dawley rats weighing 250-350?g Dosage:0.6?mg/kg Administration:Administered i.p. alone or concomitantly with Escitalopram (2?mg/kg) for 2 days Result:Short-term administration (0.6?mg/kg/day for 2 days; i.p.) alone had no effect on these parameters, its co-administration counteracted the inhibitory effect of escitalopram on the firing activity of DA neurons, resulting in a recovery to control level.

——

GPCR/G Protein

5-HT Receptor

5-HT Receptor

——

——

172895-39-5

407.33

C21H24Cl2N2O2

>98% (HPLC)

In Vitro:?DMSO : 62.5 mg/mL (153.44 mM; Ultrasonic (<60°C)

Cl.COc1ccc(CC2NCCc3c2[nH]c2ccc(C)cc32)c(Cl)c1OC

——

(-20℃)

With Ice Pack

≥ 2 years